JPS5321159A - 1*55disubstitutedd22pyrrolidones - Google Patents

1*55disubstitutedd22pyrrolidones

Info

Publication number
JPS5321159A
JPS5321159A JP9458977A JP9458977A JPS5321159A JP S5321159 A JPS5321159 A JP S5321159A JP 9458977 A JP9458977 A JP 9458977A JP 9458977 A JP9458977 A JP 9458977A JP S5321159 A JPS5321159 A JP S5321159A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9458977A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5531147B2 (ru
Inventor
Jieemuzu Neruson Arubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS5321159A publication Critical patent/JPS5321159A/ja
Publication of JPS5531147B2 publication Critical patent/JPS5531147B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP9458977A 1976-08-06 1977-08-06 1*55disubstitutedd22pyrrolidones Granted JPS5321159A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (2)

Publication Number Publication Date
JPS5321159A true JPS5321159A (en) 1978-02-27
JPS5531147B2 JPS5531147B2 (ru) 1980-08-15

Family

ID=24861795

Family Applications (2)

Application Number Title Priority Date Filing Date
JP9458977A Granted JPS5321159A (en) 1976-08-06 1977-08-06 1*55disubstitutedd22pyrrolidones
JP54112743A Expired JPS585196B2 (ja) 1976-08-06 1979-09-03 １，５−ジ置換−２−ピロリドン類製造のための中間体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP54112743A Expired JPS585196B2 (ja) 1976-08-06 1979-09-03 １，５−ジ置換−２−ピロリドン類製造のための中間体

Country Status (31)

Country Link
JP (2) JPS5321159A (ru)
AR (1) AR217080A1 (ru)
AT (1) AT362887B (ru)
AU (1) AU508007B2 (ru)
BE (1) BE857506A (ru)
BG (1) BG31073A3 (ru)
CA (1) CA1077948A (ru)
CH (1) CH624934A5 (ru)
CS (1) CS221269B2 (ru)
DD (2) DD143768A5 (ru)
DE (1) DE2735904A1 (ru)
DK (1) DK352077A (ru)
ES (2) ES461388A1 (ru)
FI (1) FI70009C (ru)
FR (1) FR2369260A1 (ru)
GB (2) GB1556569A (ru)
GR (1) GR68688B (ru)
HU (1) HU180273B (ru)
IE (1) IE45505B1 (ru)
IL (1) IL52615A (ru)
LU (1) LU77936A1 (ru)
NL (1) NL7708637A (ru)
NO (1) NO772752L (ru)
NZ (1) NZ184806A (ru)
PH (1) PH17398A (ru)
PL (2) PL112931B1 (ru)
PT (1) PT66891B (ru)
SE (1) SE423813B (ru)
SU (3) SU703016A3 (ru)
YU (1) YU192577A (ru)
ZA (1) ZA774704B (ru)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
WO2004065365A1 (ja) * 2003-01-21 2004-08-05 Ono Pharmaceutical Co., Ltd. ８−アザプロスタグランジン誘導体およびその医薬用途
JP2005530796A (ja) * 2002-05-14 2005-10-13 アラーガン、インコーポレイテッド 眼圧降下剤としての８−アザプロスタグランジン類似体
JP2007197467A (ja) * 2000-11-27 2007-08-09 Pfizer Prod Inc 骨粗鬆症治療用ｅｐ４受容体選択的アゴニスト
JP2012111767A (ja) * 2001-07-23 2012-06-14 Ono Pharmaceut Co Ltd Ｅｐ４アゴニストを有効成分とする骨量低下疾患の治療剤

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
JPS59137224A (ja) * 1983-01-25 1984-08-07 Mitsubishi Electric Corp 電気鉄道用き電電圧補償装置
ATE327751T1 (de) 2000-01-31 2006-06-15 Pfizer Prod Inc Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz
MXPA04005555A (es) * 2002-03-18 2005-05-16 Pfizer Prod Inc Procedimientos de tratamiento con agonistas selectivos del receptor ep4.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4975558A (ru) * 1972-05-03 1974-07-20
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4975558A (ru) * 1972-05-03 1974-07-20
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
JPS635217B2 (ru) * 1979-12-27 1988-02-02 Canon Kk
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
JP2007197467A (ja) * 2000-11-27 2007-08-09 Pfizer Prod Inc 骨粗鬆症治療用ｅｐ４受容体選択的アゴニスト
JP2012111767A (ja) * 2001-07-23 2012-06-14 Ono Pharmaceut Co Ltd Ｅｐ４アゴニストを有効成分とする骨量低下疾患の治療剤
JP2005530796A (ja) * 2002-05-14 2005-10-13 アラーガン、インコーポレイテッド 眼圧降下剤としての８−アザプロスタグランジン類似体
JP2011116768A (ja) * 2002-05-14 2011-06-16 Allergan Inc 眼圧降下剤としての８−アザプロスタグランジン類似体
WO2004065365A1 (ja) * 2003-01-21 2004-08-05 Ono Pharmaceutical Co., Ltd. ８−アザプロスタグランジン誘導体およびその医薬用途

Also Published As

Publication number Publication date
CA1077948A (en) 1980-05-20
SE7708642L (sv) 1978-02-07
GB1556570A (en) 1979-11-28
DD143768A5 (de) 1980-09-10
PL200124A1 (pl) 1978-05-22
AR217080A1 (es) 1980-02-29
JPS5555161A (en) 1980-04-22
GR68688B (ru) 1982-02-01
IL52615A0 (en) 1977-10-31
ZA774704B (en) 1978-06-28
JPS5531147B2 (ru) 1980-08-15
SE423813B (sv) 1982-06-07
YU192577A (en) 1983-04-30
IL52615A (en) 1981-09-13
IE45505L (en) 1978-02-06
CS221269B2 (en) 1983-04-29
BE857506A (fr) 1978-02-06
NL7708637A (nl) 1978-02-08
FR2369260B1 (ru) 1982-02-12
AU2751577A (en) 1979-02-08
NZ184806A (en) 1980-04-28
AT362887B (de) 1981-06-25
PH17398A (en) 1984-08-08
NO772752L (no) 1978-02-07
JPS585196B2 (ja) 1983-01-29
ATA579477A (de) 1980-11-15
FI70009B (fi) 1986-01-31
FI70009C (fi) 1986-09-12
PT66891B (en) 1979-01-26
SU850000A3 (ru) 1981-07-23
FI772376A (ru) 1978-02-07
DE2735904A1 (de) 1978-02-09
LU77936A1 (ru) 1978-04-27
ES461388A1 (es) 1978-12-01
BG31073A3 (en) 1981-10-15
DD136135A5 (de) 1979-06-20
IE45505B1 (en) 1982-09-08
DK352077A (da) 1978-02-07
AU508007B2 (en) 1980-03-06
HU180273B (en) 1983-02-28
PL112931B1 (en) 1980-11-29
GB1556569A (en) 1979-11-28
ES471349A1 (es) 1979-09-16
CH624934A5 (ru) 1981-08-31
FR2369260A1 (fr) 1978-05-26
SU703016A3 (ru) 1979-12-05
SU818480A3 (ru) 1981-03-30
PT66891A (en) 1977-09-01

Similar Documents

Publication Publication Date Title
JPS5363335A (en) Triisubstitutedd11phenyll2*3*4*55 tetrahydroo1hh33benzazepine compound
JPS5576895A (en) Novel 4*66diioo*aminoglycosyl**1*33 diaminocycritols
JPS52105181A (en) Novel 1*22dithiol derivative
JPS5344539A (en) 22*33phenyll22 aminopropionyloxy* derivatives
JPS5325567A (en) 22phenylaminooimidazolinee*2* compound
JPS52133974A (en) 1*33dihydrooheteroarylspiro*isobenzolane*
JPS5321159A (en) 1*55disubstitutedd22pyrrolidones
JPS5287194A (en) 1*33dithioro*4*55b*pyrazinee22 ylideneepropanedinitrilee44oxide
JPS537677A (en) 2*66methanoo2hh11 benzooxosines
JPS5321105A (en) Stabilized 1*1*11trichloroethane
JPS52156897A (en) 77*alphaa*2*33dihydroo22oxoo1hh benzimidazolee11ylcarbonylamino** arylacetoamide*cephalospolines
JPS5365892A (en) 33*22aminoethylthio**66*11hydroxyethyl* 77oxoo11azabicyclo*3*2*0*heptt22 enee22carboxylate
MY8400092A (en) 21 halogenopregnane compounds
AU1309176A (en) Fire-barriers
ZA77691B (en) Novel 1-sulfonyl-5(6)-substituted-benzimidazoles
JPS5356607A (en) 4*66dii00*aminoglycosyl** 1*33diaminocicrytol derivatives
JPS5655347A (en) Alkyll2*55diketogluconatee5*55dialkylacetal
JPS5411220A (en) Thimocine alpha 1
GB1542775A (en) Seldomycin factor 5 derivatives
JPS52102286A (en) 1*3*44oxadiazoleamides
NZ183615A (en) 5(6)-heterocycly carbonyl-2-alkoxycarbonylamino-benzimidazoles
JPS5325588A (en) 1*2*3*4*5*66hexahydroo1*66 methanoo33benzoazocine
JPS52108960A (en) 24*255dihydroxycalcipherol
JPS5318502A (en) Stabilized 1*1*11trichloroethane
JPS539731A (en) 2*55dichioroo44brophenylazii44 chlorophenylsulfide